Molecular templates, inc. (MTEM)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Research and development revenue

-

-

-

-

-

-

-

-

-

-

-

0

1,760

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

4,141

-

-

-

7,008

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

3,618

5,447

-

4,684

6,752

1,367

482

-

648

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

65,874

3,680

3,680

3,681

3,681

3,680

3,680

3,681

3,212

3,181

3,180

2,922

2,021

1,797

1,797

252

-

-

0

-

-

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

42

125

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

42

1,885

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

20,631

16,573

15,249

10,243

8,454

7,563

8,290

7,662

6,687

4,658

2,522

1,240

1,067

-4,275

2,271

4,016

6,005

11,369

8,081

10,141

10,680

8,609

8,906

8,664

9,653

8,533

6,350

7,983

6,468

6,163

4,039

2,897

5,687

6,742

6,481

5,068

6,097

4,773

4,954

General and administrative

5,647

6,028

4,509

4,605

4,935

3,916

3,538

3,718

2,910

3,521

3,996

2,447

1,791

-469

810

1,892

2,249

2,248

2,372

2,480

2,616

2,623

2,407

2,477

2,634

2,453

2,051

2,166

2,515

1,851

1,741

1,780

1,708

1,420

1,308

1,685

1,297

1,297

1,005

Loss on impairment of in-process research and development

-

-

22,123

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

26,278

22,601

41,881

14,848

13,389

11,479

11,828

11,380

9,597

8,179

6,518

3,687

2,858

-4,744

3,081

5,908

8,254

13,617

10,453

12,621

13,296

11,232

11,313

11,141

12,287

10,986

8,401

10,149

8,983

8,014

5,780

4,677

7,395

8,162

7,789

6,753

7,394

6,070

5,959

Loss from operations

-22,137

-16,404

-38,263

-9,401

-6,381

-6,795

-5,076

-10,013

-9,115

-7,359

-5,870

-3,645

-973

6,624

-3,081

-5,908

-8,254

52,257

-6,773

-8,941

-9,615

-7,551

-7,633

-7,461

-8,606

-7,774

-5,220

-6,969

-6,061

-5,993

-3,983

-2,880

-7,143

-8,100

-7,789

-6,753

-7,394

-6,070

-5,959

Interest and other income, net

472

874

396

543

510

444

107

118

82

49

1

1

0

-59

6

40

32

26

27

39

33

24

27

30

40

32

34

34

36

-

25

29

-

-

-

-

-

-

-

Interest and other expense, net

348

351

353

301

293

318

279

98

295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

0

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before provision for income taxes

-22,013

-

-

-

-6,168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

107

422

223

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-118

-996

370

17,430

315

596

-1,572

1,563

-341

6,665

1,457

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-

1

6

-

35

4

298

614

397

-272

2

1

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on conversion of notes

-

-

-

-

-

-

-

-

-

-

4,719

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on conversion of notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

5

12

3

14

19

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,379

-5,822

-3,116

34,356

2,967

19,852

-108,391

-

3,659

-

-

-

-

Income (loss) before provision for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,947

-

-

-7,508

1,193

-12,757

-9,141

28,388

-991

17,001

-115,533

-

-

-

-

-

-

Provision for income taxes

5

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-202

-

-

81

17

31

73

-

-

-

0

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,182

-

148

5,679

Net loss

-22,018

-

-

-

-6,168

-

-

-

-

-6,914

-10,967

-4,064

-1,195

6,880

-3,192

-6,864

-7,852

69,713

-6,431

-8,306

-11,154

-5,964

-7,745

-766

-7,109

-7,589

1,176

-12,788

-9,214

28,388

-991

17,001

-115,533

-

-4,125

-7,923

-

-5,908

-261

Deemed dividends on preferred stock

-

-

-

-

-

-

-

-

-

1

138

392

427

-

393

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

939

-

-

Net loss attributable to common shareholders

-22,018

-15,881

-38,219

-9,153

-6,168

-6,634

-5,244

-9,695

-8,714

-6,915

-11,105

-4,456

-1,622

-

-3,585

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,330

-5,908

-261

Net loss per share attributable to common shareholders:
Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,511

71,488

71,520

71,382

71,334

66,732

62,845

59,845

59,347

59,303

59,263

58,542

57,037

56,486

56,347

55,654

54,549

50,326

-

49,052

48,805

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,511

71,488

83,003

71,382

72,815

66,732

67,752

61,494

62,998

61,300

54,244

63,561

57,037

56,486

38,651

64,405

63,494

50,326

-

49,052

48,805

-

-

-

Basic and diluted

-0.48

-0.41

-1.03

-0.25

-0.17

-0.15

-0.19

-0.36

-0.32

26.83

-0.62

-20.76

-7.56

-

-11.89

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.18

-0.01

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.11

1.00

-0.09

-0.12

-0.17

-0.10

-0.13

-0.01

-0.12

-0.13

0.02

-0.22

-0.16

0.70

-0.02

0.31

-2.30

-

-0.08

-0.16

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.11

0.92

-0.09

-0.12

-0.17

-0.08

-0.15

-0.12

-0.14

-0.03

-0.08

-0.22

-0.16

1.09

-0.06

-0.04

-2.30

-

-0.08

-0.16

-

-

-

Weighted average number of shares used in net loss per share calculations:
Basic and diluted

45,649

40,584

36,937

36,819

36,738

36,674

27,680

27,062

26,989

27,248

17,925

214

214

-

301

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common shareholders

-22,018

-15,881

-38,219

-9,153

-6,168

-6,634

-5,244

-9,695

-8,714

-

-11,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive loss:
Unrealized gain (loss) on available-for-sale securities

-

-

-

-

-

-

-

-

0

0

0

0

0

-26

0

4

22

-18

15

-3

-2

-17

-13

4

-15

-10

65

-33

-5

-3

27

-14

2

8

-7

1

-4

-

-

Comprehensive loss

-

-

-

-

-

-

-

-

-8,714

-6,915

-11,105

-4,456

-1,622

5,675

-3,585

-6,860

-7,830

69,695

-6,416

-8,309

-11,156

-5,981

-7,758

-762

-7,124

-7,599

1,241

-12,821

-9,219

28,385

-964

16,987

-115,531

-5,267

-4,132

-7,922

-8,334

-

-

Weighted average number of shares used in per common share calculations: basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,445

33,672

33,638

Grant
Total revenue

2,341

-

-

-

595

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

431

236

-

607

4,721

423

251

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-